Have You Been Prescribed GLP-1 Weight Loss Injections Through the NHS? Take Part in an Important University of Oxford Study

Cohesive Society CIC is pleased to support the sharing of an important research opportunity being led by a PhD student at the University of Oxford.

The study is seeking to hear from adults in England who have been prescribed GLP-1 weight loss injections through the NHS, either by a GP or a specialist, and who may be willing to share their experiences in a one-hour interview by telephone or Microsoft Teams.

This is a valuable opportunity for members of our community, service users, advisory board members, volunteers, readers, and the wider public to help shape understanding of how this treatment is experienced in real life and how care in general practice may be improved.

Why this research matters

GLP-1 medications such as liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Mounjaro) are increasingly discussed in relation to weight management and healthcare access. However, behind every prescription is a real person with a real experience.

This Oxford-led research aims to better understand:

• What it has been like for people to take GLP-1 medication for weight loss through the NHS

• How patients experience this form of care

• What could be improved in general practice and wider NHS support

Studies like this can help ensure that future services are shaped not only by policy and prescribing figures but also by patients’ lived realities.

Who can take part?

According to the study information, you may be eligible to participate if you:

• are 18 or over

• live in England

• have been prescribed a GLP-1 injection through the NHS for weight loss

• are not receiving the medication as part of a clinical trial

Please note: this study is only for people who have already been prescribed these injections through the NHS. It is not a route to request, access, or obtain treatment.

What does participation involve?

Participants will be invited to take part in a one-hour interview, either:

• by phone, or

• via Microsoft Teams

Those who take part will receive an Amazon voucher in recognition of their time and contribution.

Ethical approval

The study has received ethical approval from the University of Oxford under reference number 1271148.

This should reassure prospective participants that the research has undergone formal academic review and approval processes.

A message from Cohesive Society CIC

At Cohesive Society CIC, we believe that communities should have a voice in the services, policies, and systems that affect their lives. Research of this nature is especially important because it allows ordinary people to influence future understanding of healthcare access, patient experience, and service improvement.

We therefore warmly encourage our:

• members

• beneficiaries and service recipients

• volunteers

• advisory board members

• readers and supporters

• and the wider public

to consider joining this research if they wish to do so and if they meet the participation criteria.

Your voice, experience, and perspective may help inform better care for others in the future.

Interested in taking part?

If you would like to express your interest through Cohesive Society CIC, please contact us and we will help direct your enquiry appropriately.

Email: info@cohesivesociety.org
Website: www.cohesivesociety.org

You may contact us by email or through the contact form on our website to indicate that you would like to join this initiative.

Final note

Cohesive Society CIC is sharing this opportunity as part of our commitment to supporting public awareness, community engagement, and informed participation in meaningful research. Participation is entirely voluntary.

If you are eligible and feel comfortable sharing your experience, we encourage you to come forward and contribute to this important study.